The $0.5609 payout on NLY.PR.J marks an 8.6% forward yield, payable to shareholders of record June 1. Annaly Capital Management’s 8.875% Cumulative Preferred Series J (NLY.PR.J) announced a $0.5609 per share quarterly dividend. The payout equates to an 8.6% forward yield b
HSBC completes lending review after $400M provision HSBC has substantially completed its lending review. The review follows a $400M provision over a UK fraud. HSBC shares rose 0.85% to $89.73 after the news.
Marcus & Millichap expands share repurchase program and projects higher service costs for Q2 2026 amid 18% revenue growth. Marcus & Millichap increased its share repurchase authorization by $70 million, signaling confidence in its financial position. The company expects Q2
Biotech firm BioAge reports a Q1 GAAP loss of $0.52 per share as revenue reaches $2.8 million. BioAge Labs reported a first-quarter GAAP loss of $0.52 per share, matching its revenue of $2.8 million for the period. The company’s financial results reflect ongoing investment
Brookfield Asset Management maintains its quarterly payout at $0.5025, matching prior periods with a 4.12% forward yield. Brookfield Asset Management Ltd. (BAM) announced a quarterly dividend of $0.5025 per share, unchanged from its previous distribution. The payout yields
Atossa Therapeutics reports a wider Q1 GAAP loss as operating expenses rise to $9.9 million from $7.4 million a year earlier. Atossa Therapeutics reported a first-quarter GAAP loss of $1.11 per share, reflecting increased financial pressure. The company’s net loss widened
Quest Resource Holding Corporation sees sequential gross profit growth Quest Resource Holding Corporation made a $2M early term debt payment in Q1 2026. The company cited typical seasonality alongside incremental uplift. The company's first quarter marked a stead
The semiconductor software firm targets non-GAAP operating profitability after Q1 results exceeded midpoint expectations. Silvaco Group Inc. projected Q2 revenue of $18M, plus or minus 10%, as it prioritizes non-GAAP operating profitability. The guidance follows a Q1 where
Monster Beverage (MNST) started off 2026 with a strong first quarter, posting record sales of $2.35B on 27% growth. Notably, demand remained robust across the company's energy drink portfolio Operating income rose 28.1% to $730.0M, net income increased 28.6% to $569
bioAffinity Technologies press release (BIAF): Q1 GAAP EPS of -$0.81. - Revenue of $1.35M. Cash and cash equivalents as of March 31, 2026, were $3.1 million, compared with $6.4 million as of December 31, 2025
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.